Access site bleeding after transcatheter aortic valve implantation

Abhishek Sharma, Armin Arbab-Zadeh, Divyanshu Dubey, Jacob Shani, Jason Lazar, Robert Frankel

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Surgical aortic valve replacement improves morbidity and mortality in patients with severe aortic valve stenosis and is treatment of choice for symptomatic patients. As high, one-third of patients with severe AS are considered inoperable due to associated high surgical risk. Recently, transcatheter aortic valve implantation (TAVI) has been demonstrated to improve survival, quality of life, and functional status in patients who are considered inoperable due to high risk of surgery. However, access site and non-access site bleeding are major procedural complications after TAVI and are associated with worse clinical outcomes. In this review, we systematically study the access site complication associated with TAVI and approaches that can minimize these complications.

Original languageEnglish (US)
Pages (from-to)463-468
Number of pages6
JournalJournal of Thrombosis and Thrombolysis
Issue number4
StatePublished - May 2013


  • Access site bleeding
  • Aortic stenosis
  • Transcatheter aortic valve implantation (TAVI)

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Access site bleeding after transcatheter aortic valve implantation'. Together they form a unique fingerprint.

Cite this